These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2185158)

  • 1. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis.
    Weber K; Preac-Mursic V; Wilske B; Thurmayr R; Neubert U; Scherwitz C
    Infection; 1990; 18(2):91-6. PubMed ID: 2185158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.
    Dattwyler RJ; Halperin JJ; Volkman DJ; Luft BJ
    Lancet; 1988 May; 1(8596):1191-4. PubMed ID: 2897008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
    Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of Lyme borreliosis in children.
    Krbkova L; Stanek G
    Infection; 1996; 24(2):170-3. PubMed ID: 8740116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
    Dattwyler RJ; Luft BJ; Kunkel MJ; Finkel MF; Wormser GP; Rush TJ; Grunwaldt E; Agger WA; Franklin M; Oswald D; Cockey L; Maladorno D
    N Engl J Med; 1997 Jul; 337(5):289-94. PubMed ID: 9233865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
    Oksi J; Nikoskelainen J; Viljanen MK
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):715-9. PubMed ID: 9865985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.
    Weber K; Preac-Mursic V; Neubert U; Thurmayr R; Herzer P; Wilske B; Schierz G; Marget W
    Ann N Y Acad Sci; 1988; 539():324-45. PubMed ID: 3056202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
    Breier F; Kunz G; Klade H; Stanek G; Aberer E
    Infection; 1996; 24(1):69-72. PubMed ID: 8852474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New chemotherapeutic approaches in the treatment of Lyme borreliosis.
    Luft BJ; Volkman DJ; Halperin JJ; Dattwyler RJ
    Ann N Y Acad Sci; 1988; 539():352-61. PubMed ID: 3056203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
    Stupica D; Velušcek M; Blagus R; Bogovic P; Rojko T; Cerar T; Strle F
    J Antimicrob Chemother; 2018 May; 73(5):1352-1358. PubMed ID: 29385444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis.
    Yang J; Wen S; Kong J; Yue P; Cao W; Xu X; Zhang Y; Chen J; Liu M; Fan Y; Luo L; Chen T; Li L; Li B; Dong Y; Luo S; Zhou G; Liu A; Bao F
    Microbiol Spectr; 2021 Dec; 9(3):e0076121. PubMed ID: 34756070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.
    Hassler D; Zöller L; Haude M; Hufnagel HD; Heinrich F; Sonntag HG
    Infection; 1990; 18(1):16-20. PubMed ID: 2179134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
    Wormser GP; Ramanathan R; Nowakowski J; McKenna D; Holmgren D; Visintainer P; Dornbush R; Singh B; Nadelman RB
    Ann Intern Med; 2003 May; 138(9):697-704. PubMed ID: 12729423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lyme borreliosis in childhood].
    Millner M
    Padiatr Padol; 1992; 27(6):A81-93. PubMed ID: 1484707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.
    Berende A; ter Hofstede HJ; Donders AR; van Middendorp H; Kessels RP; Adang EM; Vos FJ; Evers AW; Kullberg BJ
    BMC Infect Dis; 2014 Oct; 14():543. PubMed ID: 25318999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study.
    Müllegger RR; Millner MM; Stanek G; Spork KD
    Infection; 1991; 19(4):279-83. PubMed ID: 1917046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis.
    Weber K; Wilske B; Preac-Mursic V; Thurmayr R
    Infection; 1993; 21(6):367-72. PubMed ID: 8132365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis.
    Suttorp-Schulten MS; Kuiper H; Kijlstra A; van Dam AP; Rothova A
    Am J Ophthalmol; 1993 Nov; 116(5):571-5. PubMed ID: 8238216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.